v3.26.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Nov. 20, 2025
Nov. 30, 2025
[1]
May 31, 2026
Subsidiary, Sale of Stock [Line Items]      
Proposed Public Offering to purchase   $ 20,000 $ 1,500,000
Underwriting compensation percentage     0.75%
Payments of underwriting expense     $ 750,000
Percentage of deferred underwriting discount     1.50%
Sale of stock issued     272,500
Underwriting Agreement [Member]      
Subsidiary, Sale of Stock [Line Items]      
Payments of underwriting expense     $ 100,000
Over-Allotment Option [Member]      
Subsidiary, Sale of Stock [Line Items]      
Cash underwriting discount     $ 862,500
Stock issued during period shares issued for services     86,250
Deferred underwriting compensation shares     150,000
Sale of stock issued 11,500,000   172,500
IPO [Member]      
Subsidiary, Sale of Stock [Line Items]      
Stock issued during period shares other     75,000
Sale of stock issued     100,000
[1] Includes up to an aggregate of 375,000 shares of common stock subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part (see Note 5).